Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Min Du & Jianbo Yin. (2022) Dual-Drug Nanosystem: Etoposide Prodrug and Cisplatin Coloaded Nanostructured Lipid Carriers for Lung Cancer Therapy. Drug Design, Development and Therapy 16, pages 4139-4149.
Read now
Read now
Zhaoqiang Dong, Yuzhen Wang, Jing Guo, Chuan Tian, Wengu Pan, Hongwei Wang & Jieke Yan. (2022) Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity. Drug Design, Development and Therapy 16, pages 2683-2693.
Read now
Read now
Yang Chen, Zhenyu Xu, Tingxun Lu, Jia Luo & Hua Xue. (2022) Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer. Drug Delivery 29:1, pages 2705-2712.
Read now
Read now
Agnes Cecheto Trindade, Pedro Augusto Rodrigues Ribeiro de Castro, Bruna Cristina dos Santos Pinto, Jéssica Aparecida Ribeiro Ambrósio, Benedito Marcio de Oliveira Junior, Milton Beltrame Junior, Erika Peterson Gonçalves, Juliana Guerra Pinto, Juliana Ferreira-Strixino & Andreza Ribeiro Simioni. (2022) Gelatin nanoparticles via template polymerization for drug delivery system to photoprocess application in cells. Journal of Biomaterials Science, Polymer Edition 33:5, pages 551-568.
Read now
Read now
Gamze Varan, Safiye Akkın, Nurbanu Demirtürk, Juan M. Benito & Erem Bilensoy. (2021) Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver. Journal of Drug Targeting 29:4, pages 439-453.
Read now
Read now
Zhen Liang, Juan Li & Budong Zhu. (2020) Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform. Drug Design, Development and Therapy 14, pages 4519-4531.
Read now
Read now
Yun Bian & Dong Guo. (2020) Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles. Drug Design, Development and Therapy 14, pages 647-659.
Read now
Read now
Junjian Wang. (2020) Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles. Drug Design, Development and Therapy 14, pages 823-832.
Read now
Read now
Chengsong Cao, Qun Wang & Yong Liu. (2019) Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers. Drug Design, Development and Therapy 13, pages 1087-1098.
Read now
Read now
Chen Xu, Ri-jin Song, Pei Lu, Jian-chun Chen, Yong-qiang Zhou, Gang Shen, Min-jun Jiang & Wei Zhang. (2018) pH-triggered charge-reversal and redox-sensitive drug-release polymer micelles codeliver doxorubicin and triptolide for prostate tumor therapy. International Journal of Nanomedicine 13, pages 7229-7249.
Read now
Read now
Yanqiu Zhang, Lianjun Peng, Jiahui Chu, Ming Zhang, Lizhu Sun, Bin Zhong & Qiyong Wu. (2018) pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all-trans-retinoic acid and paclitaxel for cancer combination chemotherapy. International Journal of Nanomedicine 13, pages 6499-6515.
Read now
Read now
Jia Liu, Hao Cheng, Le Han, Zhun Qiang, Xinwei Zhang, Wei Gao, Kun Zhao & Yangrong Song. (2018) Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid–polymer hybrid nanoparticles. Drug Design, Development and Therapy 12, pages 3199-3209.
Read now
Read now
Wendu Duan & Yan Liu. (2018) Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib. Drug Design, Development and Therapy 12, pages 2149-2161.
Read now
Read now
Articles from other publishers (26)
Panpan Song, Bingjie Wang, Qi Pan, Tianze Jiang, Xiangyan Chen, Miao Zhang, Jiaojiao Tao & Xia Zhao. (2023) GE11-modified carboxymethyl chitosan micelles to deliver DOX·PD-L1 siRNA complex for combination of ICD and immune escape inhibition against tumor. Carbohydrate Polymers 312, pages 120837.
Crossref
Crossref
Jessica E. Holder, Christopher Ferguson, Elisabete Oliveira, Carlos Lodeiro, Carol M. Trim, Lee J. Byrne, Emilia Bertolo & Cornelia M. Wilson. (2023) The use of nanoparticles for targeted drug delivery in non-small cell lung cancer. Frontiers in Oncology 13.
Crossref
Crossref
Obaid Afzal, Abdulmalik S. A. Altamimi, Muhammad Shahid Nadeem, Sami I. Alzarea, Waleed Hassan Almalki, Aqsa Tariq, Bismillah Mubeen, Bibi Nazia Murtaza, Saima Iftikhar, Naeem Riaz & Imran Kazmi. (2022) Nanoparticles in Drug Delivery: From History to Therapeutic Applications. Nanomaterials 12:24, pages 4494.
Crossref
Crossref
Josef Jampilek & Katarina Kralova. (2022) Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy. Pharmaceutics 14:12, pages 2706.
Crossref
Crossref
Zhijin Fan, Cheng Jiang, Yichao Wang, Kaiyuan Wang, Jade Marsh, Da Zhang, Xin Chen & Liming Nie. (2022) Engineered extracellular vesicles as intelligent nanosystems for next-generation nanomedicine. Nanoscale Horizons 7:7, pages 682-714.
Crossref
Crossref
Stefan Morarasu, Bianca Codrina Morarasu, Razvan Ghiarasim, Adina Coroaba, Crina Tiron, Radu Iliescu & Gabriel-Mihail Dimofte. (2022) Targeted Cancer Therapy via pH-Functionalized Nanoparticles: A Scoping Review of Methods and Outcomes. Gels 8:4, pages 232.
Crossref
Crossref
Ahmed Aziz, Yahya Sefidbakht, Shokouh Rezaei, Hasan Kouchakzadeh & Vuk Uskoković. (2022) Doxorubicin-loaded, pH-sensitive Albumin Nanoparticles for Lung Cancer Cell Targeting. Journal of Pharmaceutical Sciences 111:4, pages 1187-1196.
Crossref
Crossref
Hassan Arkaban, Mahmood Barani, Majid Reza Akbarizadeh, Narendra Pal Singh Chauhan, Sapana Jadoun, Maryam Dehghani Soltani & Payam Zarrintaj. (2022) Polyacrylic Acid Nanoplatforms: Antimicrobial, Tissue Engineering, and Cancer Theranostic Applications. Polymers 14:6, pages 1259.
Crossref
Crossref
Zimu Li, Yiwen Gao, Wen Li, Yongyuan Li, Hang Lv, Dan Zhang, Jingwen Peng, Wei Cheng, Lin Mei, Hongzhong Chen & Xiaowei Zeng. (2022) Charge-reversal nanomedicines as a smart bullet for deep tumor penetration. Smart Materials in Medicine 3, pages 243-253.
Crossref
Crossref
Disha Mittal, Karishma Niveria & Anita Kamra Verma. 2022. Protein Kinase Inhibitors. Protein Kinase Inhibitors
747
779
.
Prateek Srivastava, Sumit Kumar Hira & Partha Pratim Manna. 2022. 2D Nanomaterials for Energy and Environmental Sustainability. 2D Nanomaterials for Energy and Environmental Sustainability
197
221
.
Xinglong Fan, Tian Wang, Zhongyi Ji, Qingpeng Li, Hongyu Shen & Jun Wang. (2021) Synergistic combination therapy of lung cancer using lipid-layered cisplatin and oridonin co-encapsulated nanoparticles. Biomedicine & Pharmacotherapy 141, pages 111830.
Crossref
Crossref
Behrouz Foroughi-Nia, Jaleh Barar, Mohammad Yousef Memar, Ayuob Aghanejad & Soudabeh Davaran. (2021) Progresses in polymeric nanoparticles for delivery of tyrosine kinase inhibitors. Life Sciences 278, pages 119642.
Crossref
Crossref
Olivia Eskens & Samiul Amin. (2021) Challenges and effective routes for formulating and delivery of epidermal growth factors in skin care. International Journal of Cosmetic Science 43:2, pages 123-130.
Crossref
Crossref
Baohua Wang, Wenxia Hu, Hongjiang Yan, Ge Chen, Yaozhong Zhang, Junjie Mao & Lei Wang. (2021) Lung cancer chemotherapy using nanoparticles: Enhanced target ability of redox-responsive and pH-sensitive cisplatin prodrug and paclitaxel. Biomedicine & Pharmacotherapy 136, pages 111249.
Crossref
Crossref
Maryam Shetab Boushehri, Dirk Dietrich & Alf Lamprecht. (2020) Nanotechnology as a Platform for the Development of Injectable Parenteral Formulations: A Comprehensive Review of the Know-Hows and State of the Art. Pharmaceutics 12:6, pages 510.
Crossref
Crossref
Juntao Pang, Huaixin Xing, Yingui Sun, Shuo Feng & Suzhen Wang. (2020) Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab. Biomedicine & Pharmacotherapy 125, pages 109861.
Crossref
Crossref
Yong Wang, Lulu Cai, Qi Wang, Mingming Zhao, Lina Dong, Kai Xu & Jingjing Li. (2020)
Spontaneous reduction of KMnO
4
with MoS
2
quantum dots for glutathione sensing in tumors
. The Analyst 145:3, pages 836-843.
Crossref
Crossref
Chen Zhang, Doudou Zhang, Jian Liu, Jie Wang, Yusheng Lu, Junxia Zheng, Bifei Li & Lee Jia. (2019) Functionalized MoS2-erlotinib produces hyperthermia under NIR. Journal of Nanobiotechnology 17:1.
Crossref
Crossref
Jinli Wang, Gaoxing Su, Xiaoqin Yin, Jia Luo, Rongrong Gu, Shuang Wang, Jian Feng & Bohua Chen. (2019) Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor—Afatinib: In vitro and in vivo evaluation. Biomedicine & Pharmacotherapy 120, pages 109493.
Crossref
Crossref
Shenghu Guo, Yuehua Zhang, Zheng Wu, Lei Zhang, Dongwei He, Xing Li & Zhiyu Wang. (2019) Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin. Biomedicine & Pharmacotherapy 118, pages 109225.
Crossref
Crossref
Yuan Hong, Shaomin Che, Beina Hui, Yunyi Yang, Xiaoli Wang, Xiaozhi Zhang, Yongqian Qiang & Hailin Ma. (2019) Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine. Biomedicine & Pharmacotherapy 112, pages 108614.
Crossref
Crossref
Kailash C. Petkar. 2019. Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics. Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics
35
56
.
Amit K. Goyal, Gautam Rath, Chetna Faujdar & Basant Malik. 2019. Applications of Targeted Nano Drugs and Delivery Systems. Applications of Targeted Nano Drugs and Delivery Systems
15
33
.
K. Laxmi Swetha & Aniruddha Roy. (2018) Tumor heterogeneity and nanoparticle-mediated tumor targeting: the importance of delivery system personalization. Drug Delivery and Translational Research 8:5, pages 1508-1526.
Crossref
Crossref
Sheng Tan & Guoxiang Wang. (2018) Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin. Biomedicine & Pharmacotherapy 102, pages 55-63.
Crossref
Crossref